Search - tctmd.com

Displaying 161 - 180 of 2970

Sort: Relevancy | Date

Presentation TCT 2023

TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials

Presenter: Usman Naseer

October 25, 2023

Presentation TCT 2023

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

Presenter: Doosup Shin

October 25, 2023

Presentation TCT 2023

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

Presenter: Eline Ploumen

October 25, 2023

Presentation TCT 2023

What to Do When Iliocaval Stents Fail

Presenter: Pallav Kolli

October 25, 2023

Presentation TCT 2023

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

Presenter: Juan Iglesias

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

TCT 466: Unintended deformation of stents during bifurcation PCI. An OCTOBER trial substudy

Presenter: Lene Andreasen

October 25, 2023

Presentation TCT 2023

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Presenter: Giovanni Esposito

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Presenter: Pieter Smits

October 25, 2023

Presentation TCT 2023

TCT 565: Drug-Coated Versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated With Provisional Stenting Using Drug-Eluting Stents: Randomized Study

Presenter: MEFTAH Abdelouahed

October 25, 2023

Presentation TCT 2023

TCT 1007: What lesion would you do first/what is the culprit artery ? - Is Drug Eluting Balloon, good as stents?

Presenter: Thisara Samarawickrama

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

TCT 815: Treatment of a Giant Coronary Aneurysm With Multiple Covered Stents and Ectatic Coronary Artery Disease With Drug-Coated Balloon

Presenter: Tuomas Rissanen

October 24, 2023

Presentation TCT 2023

Yes: There Is Always Room For Better Stents

Presenter: Abraham Tzafriri

October 24, 2023

Presentation TCT 2023

TCT 229: Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation

Presenter: Yong Hoon Kim

October 24, 2023

Presentation TCT 2023

TCT 351: Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion, 10-year Extended Follow-up Results

Presenter: Seung-Whan Lee

October 24, 2023

Presentation TCT 2023

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

Presenter: Wojciech Wanha

October 24, 2023

News Daily News

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

Todd Neale

October 16, 2023

Advertisement

TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

What to Do When Iliocaval Stents Fail

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

TCT 466: Unintended deformation of stents during bifurcation PCI. An OCTOBER trial substudy

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Comparing DCBs in De Novo CAD: Drugs, Design Matter

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

TCT 565: Drug-Coated Versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated With Provisional Stenting Using Drug-Eluting Stents: Randomized Study

TCT 1007: What lesion would you do first/what is the culprit artery ? - Is Drug Eluting Balloon, good as stents?

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

TCT 815: Treatment of a Giant Coronary Aneurysm With Multiple Covered Stents and Ectatic Coronary Artery Disease With Drug-Coated Balloon

Yes: There Is Always Room For Better Stents

TCT 229: Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation

TCT 351: Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion, 10-year Extended Follow-up Results

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content